Latest Advances in Lung Cancer Research

Study reveals 1 in 12 advanced lung cancer patients died from COVID-19 during the Omicron wave, highlighting the variant’s significant risk despite lower severity.

At 22, Leah Hubbard faces advanced lung cancer potentially linked to teenage pregnancy, challenging assumptions about the disease and raising awareness.

At the 2023 World Conference, lung cancer advocacy triumphed with a 25% funding boost for the Lung Cancer Research Program, thanks to strategic lobbying and a unified advocacy platform.

Study reveals multiple pregnancies and extended breastfeeding reduce women’s lung cancer risk, suggesting reproductive factors influence cancer screening and prevention.

Experts recommend enhanced lung cancer screening, accessible treatments, and increased research funding to prevent deaths and support affected individuals.

VA study reveals unique cancer patterns in Native American and Alaska Native veterans, informing tailored care and prevention efforts.

A study reveals that Black lung cancer patients are diagnosed younger and with more advanced stages than white patients, highlighting racial disparities in healthcare.

New US guidelines lower lung cancer screening age to 50 and reduce smoking history requirement to 20 pack-years, expanding preventative scans to save more lives.

The FDA granted orphan drug status to Quratusugene ozeplasmid, a promising gene-based therapy for small cell lung cancer, to expedite its development.

A recent multicenter study published in The Lancet highlights the promising efficacy of immunotherapy in advanced lung cancer patients.

The Monarch Platform robotic tool has revolutionized the way lung cancer is diagnosed and treated at Baptist Health. This cutting-edge technology provides a real-time, high-definition view of the airways, enabling doctors to identify and biopsy suspicious lung nodules with increased accuracy.

Scientists discover new link between air pollution and lung cancer, finding tiny particles trigger genetic changes, leading to new prevention and treatment opportunities.